LABORATORIOS FARMACEUTICOS ROVI, S.A. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 84.3 EUR | +1.93% |
|
+6.10% | +40.03% |
| Apr. 02 | Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment | MT |
| Mar. 12 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |
Quotes 5-day view
Delayed Quote BME| 2024-04-25 | 2024-04-26 | 2024-04-29 | 2024-04-30 | |
|---|---|---|---|---|
| Last | 84.7 € | 85 € | 82.7 € | 84.3 € |
| Volume | 159 176 | 79 264 | 67 230 | 57 558 |
| Change | +6.41% | +0.35% | -2.71% | +1.93% |
| Opening | 78.80 | 84.15 | 83.60 | 82.75 |
| High | 86.90 | 85.30 | 85.00 | 84.95 |
| Low | 78.60 | 82.50 | 81.60 | 82.65 |
Performance
| 1 day | +1.93% | ||
| 1 week | +6.10% | ||
| Current month | +4.20% | ||
| 1 month | +4.20% | ||
| 3 months | +37.86% | ||
| 6 months | +70.99% | ||
| Current year | +40.03% | ||
| 1 year | +109.81% | ||
| 3 years | +73.28% | ||
| 5 years | +368.33% | ||
| 10 years | +764.62% |
Volumes
marketsDaily volume
57 558
Estimated daily volume
125 653
Avg. Volume 20 sessions
66 861
Daily volume ratio
1.88
Avg. Volume 20 sessions
5 636 382.30
Avg. Volume 20 sessions USD
6 013 738.09
Record volume 1
6 097 828
Record volume 2
3 274 738
Record volume 3
2 389 799
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
4 378 018 989
Capitalization (USD)
4 671 127 360
Net sales (EUR)
829 500 000
Net sales (USD)
885 035 025
Number of employees
1 925
Sales / Employee (EUR)
430 909
Sales / Employee (USD)
459 758
Free-Float
35.68 %
Free-Float capitalization (EUR)
1 628 370 681
Free-Float capitalization (USD)
1 737 390 098
Average Daily Capital Traded
0.13%
Highs and lows
1 week
78.60
86.90
1 month
77.7586.90
Current year
60.3586.90
1 year
37.9686.90
3 years
35.2086.90
5 years
17.3086.90
10 years
7.9086.90
Indicators
Moving average 5 days
83.26
Moving average 20 days
81.52
Moving average 50 days
78.08
Moving average 100 days
70.20
Price spread / (MMA5)
-1.23%
Price spread / (MMA20)
-3.30%
Price spread / (MMA50)
-7.38%
Price spread / (MMA100)
-16.72%
STIM
RSI 9 days
56.29
RSI 14 days
57.67
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +1.93% | +6.10% | +40.03% | +109.81% | 4.67B | ||
| +5.95% | +4.75% | +34.00% | +97.32% | 704B | ||
| -1.89% | -0.62% | +26.89% | +56.67% | 577B | ||
| -1.52% | -3.32% | -7.75% | -11.67% | 348B | ||
| -0.69% | +1.84% | +18.53% | +11.91% | 327B | ||
| +0.69% | -4.07% | +4.95% | +7.62% | 288B | ||
| +1.08% | +8.00% | +14.81% | +3.36% | 234B | ||
| +0.20% | +1.93% | +4.93% | -2.28% | 198B | ||
| -0.27% | -2.30% | -9.78% | -21.31% | 194B | ||
| -0.88% | +0.15% | -4.89% | +14.27% | 147B | ||
| -0.08% | -2.66% | -11.01% | -34.12% | 145B | ||
| +1.35% | +5.57% | +3.70% | -6.92% | 124B | ||
| +2.09% | +3.51% | +17.85% | +17.44% | 85.62B | ||
| -1.12% | -2.73% | -19.52% | -20.69% | 81.3B | ||
| -.--% | +1.73% | - | - | 63.66B | ||
| -0.54% | +14.41% | +37.78% | +15.85% | 65.32B | ||
| Average | +0.42% | +1.63% | +10.03% | +15.82% | ||
| Weighted average by Cap. | -0.12% | +1.25% | +13.48% | +27.54% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
b11935706736d0f450fd528e.F-0O63xTRD1P0QcKyBIWZ2JTr50LD_lLUXhVV_Zcm-M.X6I7jxAGLxB8lm1hu0NyJDI3-axsYZM9fBkdPaNk0pt6lF_YBRo1eCmhSg
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 11:35:10 am | 84.3 | 25 | 45,489 |
| 11:35:10 am | 84.3 | 48 | 45,464 |
| 11:35:10 am | 84.3 | 86 | 45,416 |
| 11:35:10 am | 84.3 | 122 | 45,330 |
| 11:35:10 am | 84.3 | 523 | 45,208 |
| 11:35:10 am | 84.3 | 259 | 44,685 |
| 11:35:10 am | 84.3 | 192 | 44,426 |
| 11:35:10 am | 84.3 | 36 | 44,234 |
| 11:35:10 am | 84.3 | 56 | 44,198 |
Monthly variations
Annual change
| 2024 | +40.03% | ||
| 2023 | +66.94% | ||
| 2022 | -51.14% | ||
| 2021 | +94.72% | ||
| 2020 | +55.33% | ||
| 2019 | +39.83% | ||
| 2018 | +11.50% | ||
| 2017 | +26.93% | ||
| 2016 | -14.61% | ||
| 2015 | +40.19% | ||
| 2014 | +3.21% | ||
| 2013 | +88.30% | ||
| 2012 | +4.13% | ||
| 2011 | +6.04% | ||
| 2010 | -37.98% | ||
| 2009 | +32.53% | ||
| 2008 | -45.67% | ||
| 2007 | +7.50% |
- Stock Market
- Equities
- ROVI Stock
- Quotes Laboratorios Farmaceuticos Rovi, S.A.
